View Patient Profile
Brian Stickle
Dennis Wheal
Gladys Glartock
Kendall Stridor
Lewis Stoole
Luby Duboise
Ramona Peres
Skip Abeatson
Virginia Lepew
Brian Stickle
DEMOGRAPHICS
Age: 50
Gender: M
Race: African American
Allergies: NKDA
DIAGNOSIS
Primary:
1) Cryptococcal meningitis
2) Human immunodeficiency virus (HIV)
VITAL SIGNS
BP 132/89 mmHg
HR 70 bpm
RR 20 rpm
T 99.3°F oral
Ht 6'0"
Wt 264 lb
CURRENT LABS
Sodium 140 mEq/L
Potassium 4 mEq/L
Chloride 106 mEq/L
CO2 content 28 mEq/L
BUN 30 mg/dL
Serum creatinine 2.8 mg/dL
Glucose 106 mg/dL
Hemoglobin 16.2 g/dL
Hematocrit 49%
Platelets 281,000/mm3
WBC 20,600/mm3 with 75% PMN, 18% bands, 3% lymphocytes, 4% monocytes
Lymphocyte subset analysis: CD4 cells 380/mm3 , CD8 cells 968/mm3
HIV ultrasensitive PCR assay: HIV RNA 9240 copies/mL
Blood toxicology/alcohol screen: Negative
Head CT: Normal
CXR: Normal
Lumbar puncture/cerebral spinal fluid: WBC 700/mm3, 26% segs, 68% lymphocytes, 6% monocytes, 10 RBCs, glucose 7 mg/dL, protein 490 mg/dL
CSF culture: positive for Cryptococcus neoformans
MEDICATION PROFILE
Drug
Dose
Frequency
Admin Times
Route
FLUCONAZOLE
400 mg
QD
0800
IV
EFAVIRENZ
600 mg
QD
2100
PO
LAMIVUDINE
150 mg
QD
0800
PO
DIDANOSINE EC
200 mg
QD
0800
PO
VITAMIN, MULTIPLE
1 cap
QD
0800
PO
Dennis Wheal
DEMOGRAPHICS
Age: 57
Gender: M
Race: Caucasian
Allergies: Aspirin (rash)
DIAGNOSIS
Primary:
1) Skin infection
2) Shingles
Secondary:
3) Postherpetic neuralgia
4) Transient ischemia
VITAL SIGNS
BP 145/86 mmHg
HR 82 bpm
RR 24 rpm
T 98.1°F oral
Ht 5'9"
Wt 230 lb
CURRENT LABS
Serum creatinine 3.2 mg/dL
MEDICATION PROFILE
Drug
Dose
Frequency
Admin Times
Route
ACYCLOVIR
800 mg
5 DOSES/DAY(Q4H)
0600, 1000, 1400, 1800, 2200
PO
GABAPENTIN
600 mg
Q8H
0600, 1400, 2200
PO
CEFTAZIDIME
2 g
Q8H
0600, 1400, 2200
IV
AGGRENOX
200 mg/25 mg
BID
0800, 2000
PO
OXYCODONE/APAP 7.5 mg/500 mg
1 or 2 tabs
Q4-6H PRN
PRN
PO
Gladys Glartock
DEMOGRAPHICS
Age: 67
Gender: F
Race: African American
Allergies: Codeine (hives)
DIAGNOSIS
Primary:
1) Dyslipidemia
2) Diabetes
Secondary:
3) Diabetic peripheral neuropathy
4) Diabetic gastroparesis
VITAL SIGNS
BP 144/90 mmHg
HR 88 bpm
RR 26 rpm
T 97.4°F oral
Ht 5'4"
Wt 205 lb
CURRENT LABS
Serum creatinine 2.7 mg/dL
AST 25 IU/L
ALT 19 IU/L
MEDICATION PROFILE
Drug
Dose
Frequency
Admin Times
Route
ROSUVASTATIN
20 mg
DAILY
0800
PO
FENOFIBRATE
67 mg
DAILY
0800
PO
METFORMIN
500 mg
TID
0800, 1200, 1800
PO
PREGABALIN
300 mg
BID
0800, 2000
PO
METOCLOPRAMIDE
10 mg
AC&HS
0700, 1100, 1700, 2200
PO
Kendall Stridor
DEMOGRAPHICS
Age: 74
Gender: M
Race: Caucasian
Allergies: Sulfa (hives)
DIAGNOSIS
Primary:
1) Community-acquired pneumonia
VITAL SIGNS
BP 141/66 mmHg
HR 79 bpm
RR 26 rpm
T 99°F oral
Ht 5'8"
Wt 152 lb
CURRENT LABS
Serum creatinine 4.1 mg/dL
MEDICATION PROFILE
Drug
Dose
Frequency
Admin Times
Route
LEVOFLOXACIN
500 mg
QD
0800
IV
Lewis Stoole
DEMOGRAPHICS
Age: 63
Gender: M
Race: Caucasian
Allergies: NKDA
DIAGNOSIS
Primary:
1) Colorectal surgery prophylaxis
Secondary:
2) Ulcerative colitis
VITAL SIGNS
BP 124/85 mmHg
HR 68 bpm
RR 23 rpm
T 97.6°F oral
Ht 5'11"
Wt 170 lb
CURRENT LABS
Serum creatinine 3.1 mg/dL
MEDICATION PROFILE
Drug
Dose
Frequency
Admin Times
Route
ERTAPENEM
1 g
DAILY
0800
IV
SULFASALAZINE
500 mg
Q6H
0600, 1200, 1800, 2400
PO
Luby Duboise
DEMOGRAPHICS
Age: 78
Gender: F
Race: Caucasian
Allergies: NKDA
DIAGNOSIS
Primary:
1) Hospital-acquired (nosocomial) pneumonia
2) Congestive heart failure
Secondary:
3) Gout
VITAL SIGNS
BP 112/60 mmHg
HR 69 bpm
RR 21 rpm
T 98°F oral
Ht 5'7"
Wt 143 lb
CURRENT LABS
Serum creatinine 1.2 mg/dL
MEDICATION PROFILE
Drug
Dose
Frequency
Admin Times
Route
ALLOPURINOL
300 mg
QD
0800
PO
DIGOXIN
0.25 mg
QD
0800
PO
PIPERACILLIN/TAZOBACTAM
4.5 g
Q6H
0600, 1200, 1800, 2400
IV
Ramona Peres
DEMOGRAPHICS
Age: 77
Gender: F
Race: Hispanic
Allergies: Penicillin (rash)
DIAGNOSIS
Primary:
1) Deep vein thrombosis
Secondary:
2) Hypertension uncontrolled
3) Diabetes mellitus not assessed
4) Alzheimer's disease, significant impairment, poor self-care
5) Open angle glaucoma not assessed
6) Anemia, unknown etiology
VITAL SIGNS
BP 162/74 mmHg
HR 72 bpm
RR 21 rpm
T 98°F oral
Ht 5'5"
Wt 170 lb
CURRENT LABS
Sodium 143 mEq/L
Potassium 3.7 mEq/L
Chloride 110 mEq/L
CO2 content 26 mEq/L
BUN 13 mg/dL
Serum creatinine 1.1 mg/dL
Glucose 102 mg/dL
Hemoglobin A1c 7.9%
PT 17 sec
INR 1.31
Hemoglobin 12.1 g/dL
Hematocrit 33.6%
Platelets 172,000/mm3
WBC 4.8 k/mm3
RBC 3.96 m/mm3
MEDICATION PROFILE
Drug
Dose
Frequency
Admin Times
Route
GLIPIZIDE
2.5 mg
DAILY
0800
PO
BENAZEPRIL
20 mg
DAILY
0800
PO
RISPERIDONE
0.5 mg
DAILY
0800
PO
DONEPEZIL
10 mg
BEDTIME
2200
PO
BRIMONIDINE TART
0.2%
DAILY
0800
OPHTHAL
ASPIRIN E.C.
325 mg
DAILY
0800
PO
ENOXAPARIN
80 mg
TWICE DAILY
0800, 2000
SUBQ
WARFARIN
10 mg
DAILY
0800
PO
Skip Abeatson
DEMOGRAPHICS
Age: 49
Gender: M
Race: Hispanic
Allergies: NKDA
DIAGNOSIS
Primary:
1) Complicated appendicitis
Secondary:
2) Atrial fibrillation
VITAL SIGNS
BP 131/76 mmHg
HR 72 bpm
RR 24 rpm
T 98°F oral
Ht 6'1"
Wt 180 lb
CURRENT LABS
Serum creatinine 2.2 mg/dL
PT 25 sec
INR 3.31
MEDICATION PROFILE
Drug
Dose
Frequency
Admin Times
Route
WARFARIN
2.5 mg
DAILY
0800
PO
SOTALOL
80 mg
BID
0800, 2000
PO
MEROPENEM
1 g
Q8H
0600, 1400, 2200
IV
Virginia Lepew
DEMOGRAPHICS
Age: 87
Gender: F
Race: Asian
Allergies: NKDA
DIAGNOSIS
Primary:
1) Vaginal trichomoniasis
Secondary:
2) Osteoporosis
VITAL SIGNS
BP 101/58 mmHg
HR 61 bpm
RR 20 rpm
T 97.1°F oral
Ht 5'0"
Wt 90 lb
CURRENT LABS
Serum creatinine 4.5 mg/dL
MEDICATION PROFILE
Drug
Dose
Frequency
Admin Times
Route
ALENDRONATE
10 mg
DAILY
0800
PO
DOXYCYCLINE
100 mg
Q12H
0800, 2200
PO
METRONIDAZOLE
500 mg
Q12H
0800, 2200
PO
Run Clinical Report
Click to Select
Antibiotic Drugs
Anticoagulant Drugs
Diabetes Drugs
Food-Drug Interactions
Hepatic Metabolized Drugs
IV-To-PO Drug Conversions
Pain Management Drugs
Patient Safety Goals
Renal Dosing Drugs
Patient Name
Report
Code
Agent
Brian Stickle
A
A0001
LOOK FOR C & S RESULTS
Dennis Wheal
A
A0001
LOOK FOR C & S RESULTS
Kendall Stridor
A
A0001
LOOK FOR C & S RESULTS
Lewis Stoole
A
A0001
LOOK FOR C & S RESULTS
Luby Duboise
A
A0001
LOOK FOR C & S RESULTS
Skip Abeatson
A
A0001
LOOK FOR C & S RESULTS
Virginia Lepew
A
A0001
LOOK FOR C & S RESULTS
Patient Name
Report
Code
Agent
Dennis Wheal
C
C0009
AGGRENOX (ASA,DIPYRIDAMOLE)
MONITOR INR,PT
Ramona Peres
C
C0001
WARFARIN (COUMADIN)
MONITOR INR, PT OR PTT
Ramona Peres
C
C0005
ENOXAPARIN (LOVENOX)
MONITOR INR, PT OR PTT
Ramona Peres
C
C0003
ASPIRIN
MONITOR INR, PT OR PTT
Skip Abeatson
C
C0001
WARFARIN (COUMADIN)
MONITOR INR, PT OR PTT
Patient Name
Report
Code
Agent
Gladys Glartock
D
D0001
DIABETIC MEDICATION
Ramona Peres
D
D0001
DIABETIC MEDICATION
Ramona Peres
D
D0002
ATYPICAL ANTIPSYCHOTIC
MONITOR FOR HYPERGLYCEMIA
Patient Name
Report
Code
Agent
Gladys Glartock
F
F0011
GRAPEFRUIT JUICE
DESCRIPTION WHILE ON THIS DRUG AVOID GRAPEFRUIT AND GRAPEFRUIT JUICE.
Ramona Peres
F
F0001
VITAMIN K FOODS
AVOID FOODS WITH HIGH LEVELS OF VITAMIN K.
Skip Abeatson
F
F0001
VITAMIN K FOODS
AVOID FOODS WITH HIGH LEVELS OF VITAMIN K.
Skip Abeatson
F
F0011
GRAPEFRUIT JUICE
DESCRIPTION WHILE ON THIS DRUG AVOID GRAPEFRUIT AND GRAPEFRUIT JUICE.
Virginia Lepew
F
F0031
ALENDRONATE ON EMPTY STOM
TAKE FOSAMAX 30MIN BEFORE FIRST BITE OF FOOD, BEVERAGE, OR DRUG OF THE DAY. SIT UP FOR 30 MINUTES AFTER TAKING FOSAMAX
Virginia Lepew
F
F0009
DAIRY FOODS
DAIRY FOODS REDUCE ABSORPTION. TAKE 1 HR BEFORE OR 2HR AFTER DAIRY FOODS.
Patient Name
Report
Code
Agent
Gladys Glartock
H
H0008
FENOFIBRATE (TRICOR)
REGULAR PERIODIC MONITORING FOR DURATION OF THERAPY. IF LFTS ARE >3 TIMES ULN, STOP DRUG.
Gladys Glartock
H
H0005
ROSUVASTATION (CRESTOR)
BASELINE LFT AT 2, 12 WEEKS AFTER INITIATION OR DOSE INCREASE & Q6 MONTHS. IF LFT INCREASE, REPEAT TESTS UNTIL RETURN TO NORMAL. IF >3 TIMES ULN OCCURS AND PERSISTS, STOP DRUG. ABNORMALITIES USUALLY OCCUR IN FIRST 3 MONTHS.
Patient Name
Report
Code
Agent
Patient Name
Report
Code
Agent
Dennis Wheal
P
P0001
PAIN MED CLINICAL MONITORING
MONITOR PAIN MED USAGE
Patient Name
Report
Code
Agent
Dennis Wheal
S
S0012
PATIENT SAFETY GOALS:NARCOTIC
PATIENT ON ANARCOTIC/ANALGESIC IF NARC/ANALGESIC CAUSES SOMNOLENCE--PT MAY BE AT INCREASED RISK FOR FALLS SCORE = 1
Dennis Wheal
S
S0009
PATIENT SAFETY GOALS:ANTI-CONV
ANTI-CONVULSANTS MAY CAUSE ATAXIA AND BONE LOSS. PATIENT MAY BE AT AN INCREASE RISK FOR FALLS. SCORE = 1
Gladys Glartock
S
S0009
PATIENT SAFETY GOALS:ANTI-CONV
ANTI-CONVULSANTS MAY CAUSE ATAXIA AND BONE LOSS. PATIENT MAY BE AT AN INCREASE RISK FOR FALLS. SCORE = 1
Ramona Peres
S
S0015
PT SAFETY GOALS:ATYP. ANTIPSYC
PT ON ATYPICAL ANTIPSYCHOTIC MAY BE AT INCREASED RISK FOR FALL. SCORE = 3
Patient Name
Report
Code
Agent
Brian Stickle
R
R0083
FLUCONAZOLE (DIFLUCAN)
Dennis Wheal
R
R0024
GABAPENTIN (NEURONTIN)
Dennis Wheal
R
R0067
CEFTAZIDIME (TAZIDIME,FORTAZ)
Dennis Wheal
R
R0093
ACYCLOVIR (ZOVIRAX)
Gladys Glartock
R
R0032
METOCLOPRAMIDE (REGLAN)
Gladys Glartock
R
R0140
FENOFIBRATE (TRICOR)
Gladys Glartock
R
R0133
PREGABALIN (LYRICA)
Gladys Glartock
R
R0030
METFORMIN (GLUCOPHAGE)
Gladys Glartock
R
R0131
ROSUVASTATIN (CRESTOR)
Kendall Stridor
R
R0031
LEVOFLOXACIN (LEVAQUIN)
Lewis Stoole
R
R0136
ERTAPENEM (INVANZ)
Lewis Stoole
R
R0055
SULFASALAZINE (AZULFIDINE)
Luby Duboise
R
R0002
ALLOPURINOL (ZYLOPRIM)
Luby Duboise
R
R0016
DIGOXIN (LANOXIN)
Luby Duboise
R
R0079
PIP/TAZO (ZOSYN)
Ramona Peres
R
R0043
RISPERIDONE (RISPERDAL)
Ramona Peres
R
R0005
BENAZEPRIL (LOTENSIN)
Skip Abeatson
R
R0062
MEROPENEM (MERONEM)
Skip Abeatson
R
R0049
SOTALOL (BETAPACE)
Virginia Lepew
R
R0087
DOXYCYCLINE
Virginia Lepew
R
R0053
ALENDRONATE (FOSAMAX)
Virginia Lepew
R
R0033
METRONIDAZOLE (FLAGYL)